Suppr超能文献

顶端膜抗原 1 的主要抗原逃逸残基簇 c1 的丙氨酸突变。

Alanine mutagenesis of the primary antigenic escape residue cluster, c1, of apical membrane antigen 1.

机构信息

Department of Epitope Mapping, Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, 503 Robert Grant Ave., Silver Spring, MD 20910, USA.

出版信息

Infect Immun. 2010 Feb;78(2):661-71. doi: 10.1128/IAI.00866-09. Epub 2009 Nov 30.

Abstract

Antibodies against apical membrane antigen 1 (AMA1) inhibit invasion of Plasmodium merozoites into red cells, and a large number of single nucleotide polymorphisms on AMA1 allow the parasite to escape inhibitory antibodies. The availability of a crystal structure makes it possible to test protein engineering strategies to develop a monovalent broadly reactive vaccine. Previously, we showed that a linear stretch of polymorphic residues (amino acids 187 to 207), localized within the C1 cluster on domain 1, conferred the highest level of escape from inhibitory antibodies, and these were termed antigenic escape residues (AER). Here we test the hypothesis that immunodampening the C1 AER will divert the immune system toward more conserved regions. We substituted seven C1 AER of the FVO strain Plasmodium falciparum AMA1 with alanine residues (ALA). The resulting ALA protein was less immunogenic than the native protein in rabbits. Anti-ALA antibodies contained a higher proportion of cross-reactive domain 2 and domain 3 antibodies and had higher avidity than anti-FVO. No overall enhancement of cross-reactive inhibitory activity was observed when anti-FVO and anti-ALA sera were compared for their ability to inhibit invasion. Alanine mutations at the C1 AER had shifted the immune response toward cross-strain-reactive epitopes that were noninhibitory, refuting the hypothesis but confirming the importance of the C1 cluster as an inhibitory epitope. We further demonstrate that naturally occurring polymorphisms that fall within the C1 cluster can predict escape from cross-strain invasion inhibition, reinforcing the importance of the C1 cluster genotype for antigenic categorization and allelic shift analyses in future phase 2b trials.

摘要

针对顶膜抗原 1(AMA1)的抗体可抑制疟原虫裂殖子侵入红细胞,AMA1 上大量的单核苷酸多态性使寄生虫能够逃避抑制性抗体。晶体结构的可用性使得可以测试蛋白质工程策略,以开发单价广泛反应性疫苗。以前,我们表明位于结构域 1 的 C1 簇内的多态性残基(氨基酸 187 至 207)的线性延伸赋予了逃避抑制性抗体的最高水平,这些被称为抗原逃逸残基(AER)。在这里,我们检验了这样一种假设,即免疫减弱 C1 AER 将使免疫系统转向更保守的区域。我们用丙氨酸残基(ALA)取代了 FVO 株恶性疟原虫 AMA1 的七个 C1 AER。与天然蛋白相比,由此产生的 ALA 蛋白在兔子中免疫原性较低。抗-ALA 抗体包含更高比例的交叉反应性结构域 2 和结构域 3 抗体,并且比抗-FVO 具有更高的亲和力。当比较抗-FVO 和抗-ALA 血清抑制入侵的能力时,未观察到交叉反应性抑制活性的总体增强。C1 AER 的丙氨酸突变使免疫反应转向非抑制性的交叉株反应性表位,这反驳了该假说,但证实了 C1 簇作为抑制性表位的重要性。我们进一步证明,属于 C1 簇的天然发生的多态性可以预测逃避交叉株入侵抑制,从而强调了 C1 簇基因型在未来 2b 期临床试验中的抗原分类和等位基因转变分析中的重要性。

相似文献

3
Structural basis of antigenic escape of a malaria vaccine candidate.一种疟疾候选疫苗抗原逃逸的结构基础。
Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12488-93. doi: 10.1073/pnas.0701464104. Epub 2007 Jul 16.

引用本文的文献

6
Designing malaria vaccines to circumvent antigen variability.设计疟疾疫苗以规避抗原变异性。
Vaccine. 2015 Dec 22;33(52):7506-12. doi: 10.1016/j.vaccine.2015.09.110. Epub 2015 Nov 1.
7
Recent advances in recombinant protein-based malaria vaccines.基于重组蛋白的疟疾疫苗的最新进展。
Vaccine. 2015 Dec 22;33(52):7433-43. doi: 10.1016/j.vaccine.2015.09.093. Epub 2015 Oct 11.

本文引用的文献

10
Structural basis of antigenic escape of a malaria vaccine candidate.一种疟疾候选疫苗抗原逃逸的结构基础。
Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12488-93. doi: 10.1073/pnas.0701464104. Epub 2007 Jul 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验